Medical Breakthroughs
Coverage Decisions: The Hidden Valuation Key for Diagnostic AI
When you’re pricing a diagnostic AI, especially one fighting for reimbursement, its clinical efficacy and technological…
Medical Breakthroughs
Medical Breakthroughs
Healthcare AI IPOs: The Benchmark Set by 3 Listings
2024 and 2025 were the years healthcare AI finally got its public market test, with Tempus…
Medical Breakthroughs
HeartFlow’s IPO: A New Benchmark for Diagnostic AI Exits
HeartFlow’s $364 million IPO in August 2025 just reset the board for diagnostic AI deal flow.…
Medical Breakthroughs
Health Regulatory Risk: 5 Keys to 2026 Compliance
Avoid severe penalties and reputational damage. Learn 5 keys to integrating regulatory risk rating into your…
Medical Breakthroughs
AI Health Investments: 3 Risks to Avoid in 2026
Stop losing money on AI health investments. Avoid 3 common risks like poor clinical integration; 60%…
Medical Breakthroughs
AI in Diabetic Retinopathy: Investor’s Guide to Accuracy
Autonomous AI in healthcare diagnostics is about two things: scalable, high-accuracy screening that actually changes disease…
Medical Breakthroughs
Elite Autonomous Coding: The Investor’s Performance Playbook
The promise of artificial intelligence in revenue cycle management (RCM) is immense, offering the potential to…
Medical Breakthroughs
Ambient Intelligence: The Next Frontier for Clinical Documentation
The whole field of clinical documentation, which has been a bottleneck in healthcare forever, is finally…
Medical Breakthroughs
Clinical LLMs: De-Risking AI’s Promise with Human Feedback
LLMs are showing a lot of promise in healthcare, but you can’t just plug a generic…
Medical Breakthroughs
HHS HTI-1: The New Due Diligence for AI Venture Capital
The game in healthcare AI investing is changing, and it’s not because of some new algorithm.…